Guanfacine Tablets News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Guanfacine tablets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Guanfacine Tablets Today - Breaking & Trending Today

Unichem Labs gets USFDA approval for Guanfacine tablets


Unichem Laboratories announced that it has received ANDA approval for its Guanfacine Tablets from the USFDA to market a generic version of TENEX (Guanfacine) tablets.
Unichem Laboratories announced that it has received ANDA approval for its Guanfacine Tablets, USP 1 mg and 2 mg from the United States Food and Drug Administration (USFDA) to market a generic version of TENEX (Guanfacine) Tablets 1mg and 2 mg of Promius Pharma LLC.
Guanfacine Tablets are indicated in the management of hypertension. The product will be commercialized from Unichem s Ghaziabad Plant.
The announcement was made after market hours yesterday, 4 March 2021. Shares of Unichem Laboratories rose 2.66% to settle at Rs 343.50 yesterday. ....

United States , Drug Administration , Promius Pharma , Unichem Laboratories , Guanfacine Tablets , United States Food , Capital Market , Health Care , Generic Drug , Food And Drug Administration , Tablet Computer , Pharmaceuticals Nec , Pharmaceutical Formulations , Unichems Ghaziabad , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது மாநிலங்களில் உணவு , மூலதனம் சந்தை , ஆரோக்கியம் பராமரிப்பு , ஜெநெரிக் மருந்து , டேப்லெட் கணினி , மருந்துகள் கழுத்து , மருந்து சூத்திரங்கள் ,

Nifty to open below 15,000 amidst weak global cues - The Hindu BusinessLine


Nifty to open below 15,000 amidst weak global cues
March 05, 2021
×
Most Asia-Pacific markets slumped in excess of 1% in early trade on Friday while US stocks declined overnight
The Indian markets are likely to open sharply lower on Friday, due to weak global cues and on profit booking. Cues from SGX Nifty suggest that Nifty is most likely to open below 15,000-mark. The SGX Nifty is hovering around 14,880, a decline of about 220 points, against the Nifty futures that on Thursday closed at 15,106.
Shrikant Chouhan, Executive Vice President, Equity Technical Research at Kotak Securities, said: “We witnessed a sharp decline (on Thursday) in our market mainly due to the sudden jump in the long-term bond yields of the US. The steady growth in the economy leads to a steady rise in the bond yields and therefore, the market should start offering discounts in the medium to long term.” ....

United States , Tamil Nadu , Dadra And Nagar Haveli , West Bengal , Andhra Pradesh , New Zealand General , New Zealand , Nagarani Chava , Ganesh Natarajan , Satyanarayana Chava , Nagaraj Shetti , Asia Pacific , Shrikant Chouhan , Japan Bank , Heranba Industries , Bombay High Court , Promius Pharma , Torrent Power Ltd , Unichem Laboratories , Shree Cement Ltd , Technical Research Analyst , Equity Technical Research At Kotak Securities , Rashtriya Ispat Nigam Limited , International Cooperation , Laurus Labs Ltd , Drug Administration ,

Nifty ends below 15,000-mark as rising US bond yields spook investors


Domestic equity benchmarks declined for second trading session on Friday. Resurgent worries about rising US bond yields hit global stocks. Firm crude oil prices also spooked investors. Higher crude oil prices could increase fiscal deficit, current account deficit and stoke fuel price inflation. The Nifty closed below the crucial 15,000 mark.
The S&P BSE Sensex, tumbled 440.76 points or 0.87% at 50,405.32. The Nifty 50 index slumped 142.65 points or 0.95% at 14,938.60. Both these indices have fallen a little over 2% each in two consecutive sessions.
ICICI Bank (down 1.80%), HDFC (down 1.55%), HDFC Bank (down 1.52%) and Infosys (down 1.07%) were major drags today.
Selling was broad based. The S&P BSE Mid-Cap index fell 1.89% and the S&P BSE Small-Cap index tumbled 1.50%. Both these indices saw profit taking after rallying over 5% in the past four days. ....

India General , United States , City Of , United Kingdom , Sri Lanka , Jerome Powell , Asia Pacific , Li Keqiang , Dilip Buildcon , Heranba Industries , Tejas Networks , Ministry Of Health , Promius Pharma , Railway Vikas Nigam , Welspun Corp , Authority Of India , Forum Centre City Mall , Railway Infrastructure , Max Healthcare Institute , Hindalco Industries , Drug Administration , Federal Reserve , Tata Steel , Family Welfare , Premier Li Keqiang , Federal Reserve Chair Jerome Powell ,